Agreement Between Artificial Intelligence and Anesthesiologists in Ultrasound-Guided Axillary Brachial Plexus Block

NCT07532278 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-15

No results posted yet for this study

Summary

This prospective observational study aims to evaluate the agreement between artificial intelligence (AI)-assisted target point identification and experienced anesthesiologists during ultrasound-guided axillary brachial plexus block.

Ultrasound guidance is widely used in regional anesthesia to improve block success and safety. However, accurate identification of anatomical structures and optimal injection points remains operator-dependent. Artificial intelligence-based systems have the potential to assist clinicians by identifying anatomical landmarks in real time.

In this study, AI-generated target points will be compared with those determined by experienced anesthesiologists. The level of agreement between the two methods will be analyzed. Secondary outcomes will include block performance parameters and image quality.

The findings of this study may contribute to understanding the clinical utility of AI in ultrasound-guided regional anesthesia.

Conditions

  • Ultrasound-Guided Nerve Block and Artificial Intelligence

Interventions

PROCEDURE

Ultrasound-Guided Axillary Brachial Plexus Block (Routine Clinical Practice)

Ultrasound-guided axillary brachial plexus block performed as part of routine clinical care. No additional intervention is introduced for the purposes of the study. Real-time ultrasound images obtained during the procedure will be analyzed by an artificial intelligence system and experienced anesthesiologists.

Sponsors & Collaborators

  • Gaziantep City Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-15
Primary Completion
2026-07-15
Completion
2026-07-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07532278 on ClinicalTrials.gov